Research summary, original research, 2026

Fast 3D whole-body occupational dose estimation in interventional radiology using physics-informed deep learning

Harb H, Benoit D, Pham CH, Nasr B, Bert J. Radiological physics and technology. 2026

Read the original paper

In plain language

In computer simulations, a deep learning model estimated 3D whole-body scatter dose to an interventional physician in about 0.2 seconds, closely matching slower Monte Carlo calculations. It has not yet been validated with real staff dosimetry.

At a glance

Type of study
Original research, Phantom or simulation study
Who was studied
Phantom or simulation (no people), Interventional radiologists
Summary based on
the abstract

What it found

  • The residual 3D U-Net was the best-performing model, with very low voxel-wise error and high gamma passing rates versus Monte Carlo reference dose maps.

    Key figures: mean absolute errors below 0.06 nGy; gamma passing rates exceeding 90%

  • Predicted personal dose equivalents closely matched Monte Carlo references, allowing organ-level dose estimates for superficial and deep tissues.

  • The model predicts a 3D whole-body dose distribution in about 0.2 seconds, fast enough for potential real-time use.

    Key figures: approximately 0.2 s per sample

  • Training data were GPU-accelerated Monte Carlo simulations across varying X-ray energies, C-arm angulations and physician configurations.

Limits to keep in mind

Entirely simulation-based, with the model trained and tested against Monte Carlo data rather than measurements on real staff in clinical procedures. The abstract does not report the number of simulated configurations or external validation.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.